drugset
drugset / Trial / NCT05008003

Vit D3 for Early Symptoms of COVID-19

NCT05008003 ↗

Unknown 50 enrolled Ayub Teaching Hospital Liaquat University of Medical & Health Sciences · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is aimed to investigate the treatment vitamin D3 as complementary therapy with routine care for early mild symptoms of COVID-19 in outpatients setting.

Timeline

Start
2022-09-02
Primary completion
2023-03-01
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 5000 iu —

Indications

COVID-19